Login
$XBIT
$1.85 -$0.11 (5.61%) Close

$XBIT SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Simard John, Director

Bought 70,000 shares ($143K)

12 Nov 2026 FORM 10-Q
28 Oct 2026 Form 4: Simard Jan-Paul, Co-Chief Executive Officer

Granted 2,000,000 Stock Option

28 Oct 2026 Form 3: Simard Jan-Paul, Co-Chief Executive Officer

No securities owned

28 Oct 2026 Form 4: Simard John, Director

Bought 368,524 shares ($711K)

26 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

XBiotech Inc. (“Company”) and Jan-Paul Simard (“Executive”) (collectively the “Parties”) hereby enter into this Executive Employment Agreement (the “Agreement”) on this 26th day of October, 2026 (the “Effective Date”). In consideration o...

02 Oct 2026 ARS
02 Oct 2026 Proxy statement: annual meeting on November 24, 2026

say-on-pay vote

13 Aug 2026 FORM 10-Q
14 May 2026 FORM 10-Q
29 Apr 2026 FORM 10-K/A
13 Mar 2026 FORM 10-K
11 Mar 2026 FORM S-8
23 Jan 2026 SCHEDULE 13G/A
23 Jan 2026 SCHEDULE 13G/A
09 Dec 2025 8-K: Departure/Election of Directors or Officers; Compensation

XBiotech, Inc. (“XBiotech” or the “Company”) announces that John Simard notified members of the Board of Directors beginning on December 5, 2025 of his intent to retire from his role as President and Chief Executive Officer of the Compan...

12 Nov 2025 FORM 10-Q
12 Nov 2025 Form 4: Rademaker Craig Evan, Director

Granted 92,104 Director Stock Option

12 Nov 2025 Form 4: Troy Tevi David, Director

Granted 56,000 Director Stock Option

12 Nov 2025 Form 4: Soffer David Spencer, Director

Granted 51,000 Director Stock Option

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support